Søgning
Søgning på udtrykket 'mrsa' giver 32 resultater
Dokumenter [6] Sider [2] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [4]
Dokumenter [6]
Udgivet af Sundhedsstyrelsen, 3. udgave
Udgivet af Sundhedsstyrelsen maj 2023. Findes også på www.sst.dk/-/media/Udgivelser/2023/MRSA/Information-om-behandling-af-MRSA-baerertilstand---Dansk.ashx
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
DANMAP-rapporten, der beskriver antibiotikaforbrug og resistensudviklingen i Danmark, udgives af DTU Fødevareinstituttet, DTU Veterinærinstituttet og Statens Serum Institut.
Sider [2]
…er / Pernille Ravn. 09.00-09.15 Erysipelas. Hvilken behandling er bedst? / Gruppe 5. 09.15-09.30 Strategi ved bid fra dyr / Gruppe 6. 09.30-09.45 Sammenfatning erysipelas / Pernille Ravn. 09.45-09.50 Strække ben pause. 09.50-10.00 Intro til MRSA. Præsentation af patientcase / Lotte Ebdrup. 10.00-10.45 (MR)SA ? epidemiologi, patogenese i forhold til hud og knogler / Robert Skov. 10.45-11.00 Kaffe/te ? pause. 11.00-11.20 Spondylodiskitis ? antibiotisk behandling / Gruppe 7.
… 13.45 – 14.00. Pause. 14.00 – 14.45. Behandling af urinvejsinfektion set fra KMA. Afdelingslæge Frederik Hertz, KMA, RH. 14.45 – 15.00. Kaffe og kage og frugt. 15.00 – 15.35. Bogstavbakterierne - MRSA, CPO, ESBL, VRE – forebyggelse og behandling. Afdelingslæge Frederik Hertz, KMA, RH. 15.35 – 15.45. Evaluering. Overlæge Rikke Krogh-Madsen, Hvidovre / Cheflæge Michael Dalager-Pedersen, Aalborg. .
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?
BMC Infectious Diseases
6.03.2025
. Background. Outbreaks of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have been documented at multiple sites worldwide. Several studies have reported an elevated infection rate of CA-MRSA infections in men having sex with men (MSM), suggesting CA-MRSA can behave as a sexually transmitted infection (STI).
BMC Infectious Diseases
4.03.2025
. Abstract. . Background. Outbreaks of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) have been documented at multiple sites worldwide. Several studies have reported an elevated infection rate of CA-MRSA infections in men having sex with men (MSM), suggesting CA-MRSA can behave as a sexually transmitted infection (STI).
BMC Infectious Diseases
18.02.2025
. Abstract. . Background. . Staphylococcus aureus bacteremia (SAB) is a prevalent life-threatening infection often caused by methicillin-resistant S. aureus (MRSA). Up to 30% of SAB patients fail to clear infection even with gold-standard anti-MRSA antibiotics. This phenomenon is termed antibiotic-persistent MRSA bacteremia (APMB).
BMC Infectious Diseases
13.02.2025
. Abstract. . Background. Methicillin resistant Staphylococcus aureus (MRSA) is one of the main causes of hospital-acquired infections, but the diagnosis of MRSA pseudomembranous enteritis has faded in recent years. Here, we reported a pseudomembranous enteritis case in a young male patient caused by ST5 MRSA. . . . Methods.
Clinical Microbiology and Infection
2.12.2024
To assess the frequency of the novel NaHCO3-responsive phenotype, wherein clinical methicillin-resistant Staphylococcus aureus (MRSA) isolates are rendered susceptible to standard-of-care β-lactams in the presence of NaHCO3, in a collection of 103 clinical US MRSA skin and soft tissue infection (SSTI) isolates and 22 clinical European SSTI isolates. Determined the correlation between specific phenotypic and genotypic metrics and the NaHCO3-responsive phenotype among US SSTI isolates.
Clinical Microbiology and Infection
21.11.2024
Community-onset meticillin-resistant Staphylococcus aureus (MRSA) (CO-MRSA) has been under recognised and under described outside the USA and we welcome this themed issue comprising 4 narrative reviews on the topic which cover a wide range of issues.
Clinical Microbiology and Infection
30.10.2024
Staphylococcus aureus is an important pathogen in many sites, including bloodstream, skin and soft tissue, bone and joints. When infection is caused by methicillin resistant S. aureus (MRSA) therapy is more difficult and outcomes are less favorable. Nasal colonization is associated with increased risk for MRSA infections. The nasal microbiome may play a role in risk for nasal colonization and infection.
BMC Infectious Diseases
4.10.2024
. Abstract. . Background and rationale. Methicillin resistant Staphylococcus aureus (MRSA) colonization increases the risk of MRSA infection. Detecting MRSA colonization can influence postoperative outcomes and prolong hospital stay. The conventional standard culture method for detecting MRSA colonization has limitations in terms of sensitivity and turnaround time.
BMC Infectious Diseases
18.09.2024
…4 to June 2022 and classified them into C. striatum-BSI group and contamination group; Clinical characteristics, treatments, and outcomes were compared between the C. striatum-BSI group and contamination group, Methicillin-resistant Staphylococcus aureus (MRSA)-BSI and Methicillin-resistant Staphylococcus epidermidis (MRSE)-BSI. . . . Results. Fifty-three patients with positive C. striatum blood cultures were identified.
BMC Infectious Diseases
5.09.2024
. Abstract. . Background. The increasing prevalence of methicillin-resistant Staphylococcus aureus (MRSA) strains resistant to non-beta-lactam antimicrobials poses a significant challenge in treating severe MRSA bloodstream infections. This study explores resistance development and mechanisms in MRSA isolates, especially after the first dalbavancin-resistant MRSA strain in our hospital in 2016. . .
Clinical Microbiology and Infection
17.06.2024
This review aims to explore the characteristics of outbreaks of community-acquired community-onset methicillin-resistant Staphylococcus aureus (CO-MRSA) in low prevalence areas, to understand the factors involved in its rise, and to translate this knowledge into public health policy and further research needs.
International Journal of Infectious Diseases
22.05.2024
…ssue infections, bacteremia, and endocarditis [1,2]. China Antimicrobial Resistance Surveillance System (CARSS) reported a 46% detection rate of S. aureus in 2020 [3]. The study showed that MRSA prevalence ranged from 0% to 73% at 19 sites in the Asia-Pacific region from 2000 to 2016 [3]. Recently, the rate of MRSA infection has been increasing sharply[4], posing a challenge to the health system in terms of difficult therapy, extended length of hospital stay, expanded health costs, and high mortality [4,5].
PLoS One Infectious Diseases
21.05.2024
by M. Gabriela Cabanilla, Michael L. Bernauer, Liana M. Atallah, Matthew J. Briski, Jason Koury, Cecilia M. Thompson, Chelsea N. Rodriguez, Bernadette Jakeman, Thomas F. Byrd . Background Methicillin-resistant Staphylococcus aureus (MRSA) is associated with high mortality rates. Despite antibiotic therapy, persistent bacteremia is challenging to treat.
Clinical Microbiology and Infection
16.05.2024
Gown and glove use as a component of ‘contact precautions’ was first recommended by the United States Healthcare Infection Control Practices Advisory Committee (HICPAC) in 1996 and remains widely adhered to today (1, 2).
Clinical Microbiology and Infection
23.11.2024
To evaluate the effectiveness of ceftaroline vs. vancomycin or daptomycin in the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections (MRSA-BSIs).
BMC Infectious Diseases
14.03.2025
…9%), and P. aeruginosa (n = 10; 16%). Collectively, gram negative bacteria were responsible for most BSIs (n = 41; 65%). Candida spp accounted for 9% (n = 5). Thirty-five pathogens (56%) were MDR; this included methicillin-resistant S. aureus (MRSA) (n = 7; 11%), carbapenem-resistant A. baumannii (n = 16; 25%), and P. aeruginosa (n = 6; 10%).
BMC Infectious Diseases
6.03.2025
…ins were isolated from 17 PICUs in China from 2016 to 2022, 3,147 of which were Staphylococcus aureus, ranking second among etiological agents of infections from PICUs. In 2022, Staphylococcus aureus had the highest detection rate, being 36.19%. And in 2021, MRSA had the highest detection rate, being 10.35% in Staphylococcus aureus. There were statistically significant differences in the annual detection rate of gram-positive bacteria, Staphylococcus aureus and MRSA between the years from 2016 to 2022 (P
BMC Infectious Diseases
4.03.2025
…ins were isolated from 17 PICUs in China from 2016 to 2022, 3,147 of which were Staphylococcus aureus, ranking second among etiological agents of infections from PICUs. In 2022, Staphylococcus aureus had the highest detection rate, being 36.19%. And in 2021, MRSA had the highest detection rate, being 10.35% in Staphylococcus aureus. There were statistically significant differences in the annual detection rate of gram-positive bacteria, Staphylococcus aureus and MRSA between the years from 2016 to 2022 (P
BMC Infectious Diseases
1.03.2025
… Background. Combination therapy including an aminoglycoside antibiotic and a cell-wall active agent is considered the most suitable option to treat invasive infections with methicillin-resistant Staphylococcus aureus (MRSA). Dual drug therapy enhances the effectiveness of treatment and reduces the risk of resistance development.
Aktuelle smitsomme sygdomme [4]
Aktuelle smitsomme sygdomme [4]
ECDC Communicable Disease Threats Report
12.03.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11 – 17 January 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, mpox, influenza, cholera, Marburg virus, chikungunya, measles, polio, MRSA, and mass gathering monitoring for the Jubilee of 2025 in Italy.
Eurosurveillance latest updates
8.03.2025
…d areas of intervention. . . Methods. We retrospectively analysed English surveillance data between 2018 and 2022 for Escherichia coli, Klebsiella species, Pseudomonas aeruginosa, and both meticillin-sensitive and resistant Staphylococcus aureus (MSSA, MRSA) bacteraemia. Crude incidence rates stratified by index of multiple deprivation and ethnic groups were calculated; age-adjusted rate ratios were estimated using negative binomial regression models. . . Results.
ECDC COVID-19 updates
24.01.2025
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 11 – 17 January 2025 and includes updates on respiratory virus epidemiology in the EU/EEA, mpox, influenza, cholera, Marburg virus, rabies, and chikungunya, measles, polio, MRSA, and mass gathering monitoring for the Jubilee of 2025 in Italy.
Eurosurveillance latest updates
27.09.2024
… in MDRO-negatives (472/2,020). Among 397 owner–pet pairs, we identified one pair sharing genotypically indistinguishable pathogens (0.3%). A risk factor analysis of pet ownership was performed for carriers of meticillin-resistant Staphylococcus aureus (MRSA) (OR = 0.662; 95% CI: 0.343–1.277), vancomycin-resistant enterococci (VRE) (OR = 0.764; 95% CI: 0.522–1.118) and multidrug-resistant Gram-negative bacteria (MDR-GNB) (OR = 0.819; 95% CI: 0.620–1.082).